UK markets close in 1 hour 46 minutes

Costamare Inc. (CMRE-PB)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
25.50-0.22 (-0.86%)
As of 03:59PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.35
52-week change 35.16%
S&P500 52-week change 323.06%
52-week high 326.00
52-week low 322.13
50-day moving average 325.46
200-day moving average 324.79

Share statistics

Avg vol (3-month) 31.38k
Avg vol (10-day) 32.28k
Shares outstanding 5111.43M
Implied shares outstanding 6N/A
Float 845.49M
% held by insiders 10.00%
% held by institutions 10.45%
Shares short (28 Mar 2024) 43.69k
Short ratio (28 Mar 2024) 42.66
Short % of float (28 Mar 2024) 4N/A
Short % of shares outstanding (28 Mar 2024) 4N/A
Shares short (prior month 29 Feb 2024) 42.5k

Dividends & splits

Forward annual dividend rate 41.91
Forward annual dividend yield 47.48%
Trailing annual dividend rate 30.46
Trailing annual dividend yield 31.79%
5-year average dividend yield 47.93
Payout ratio 4N/A
Dividend date 315 Apr 2024
Ex-dividend date 411 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 25.52%
Operating margin (ttm)21.43%

Management effectiveness

Return on assets (ttm)4.37%
Return on equity (ttm)16.58%

Income statement

Revenue (ttm)1.51B
Revenue per share (ttm)12.56
Quarterly revenue growth (yoy)86.40%
Gross profit (ttm)N/A
EBITDA 522.03M
Net income avi to common (ttm)354.68M
Diluted EPS (ttm)3.72
Quarterly earnings growth (yoy)-46.30%

Balance sheet

Total cash (mrq)790.4M
Total cash per share (mrq)6.68
Total debt (mrq)2.65B
Total debt/equity (mrq)108.57%
Current ratio (mrq)1.69
Book value per share (mrq)20.13

Cash flow statement

Operating cash flow (ttm)331.37M
Levered free cash flow (ttm)-53.37M